Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
The German series proving subtitles can be sexy — and wildly addictive - 2Tire Brands for Senior Drivers: Guaranteeing Security and Solace
- 3Novo and Lilly cut prices of weight-loss drugs in China
- 4Israel, Gulf states report fresh missile and drone attacks
- 5Aspect Biosystems receives funding for cellular medicine project
- Apollo's impatient old-timers are rooting for NASA's return to the moon with Artemis II launch
- Novo Nordisk slashes prices of popular weight loss and diabetes drugs
- Nigeria warns its citizens in South Africa to be cautious after march turns violent
- Excelling at Cash The board: A Manual for Monetary Essentials
- Signature Scents: A Manual for Outstanding Fragrances
- Journey through Pages: A Survey of \Plunging into Scholarly Universes\
- Finding Ideal Date Spots for Two or three Encounters
- ‘Dying of thirst’: Inside Gaza’s al-Mawasi water crisis
- Must-See Attractions in Australia
